Insight · London buyer's guide

Choosing a clinical pharmacist provider for a London PCN.

A practical guide for London PCN Clinical Directors and Practice Managers choosing a clinical pharmacist provider — written from the buying side of the table.

Why this matters in London specifically.

London is the most complex primary care economy in England. Patient populations across the 32 boroughs and the City sit at extremes of deprivation, diversity, polypharmacy and care home density — often inside the same PCN footprint. Discharge medicines reconciliation lands in primary care from Imperial, UCLH, Royal Free, North Middlesex, Whittington, Barts Health, Homerton, Newham, Whipps Cross, King's, Guy's and St Thomas', Lewisham and Greenwich, St George's, Croydon, Epsom and St Helier, Kingston, Hillingdon, West Middlesex and Chelsea and Westminster — each with its own discharge format and its own IIF clock. The wrong pharmacist provider costs your PCN a year of IIF and QOF performance and damages GP trust in pharmacist roles for the cycle that follows.

This guide is the checklist we'd use if we were sitting on the buying side of the table in a London PCN.

Frame the decision before going to market.

Before contacting a single provider, decide internally what the pharmacist role is actually for in your London PCN. Is the primary objective converting ARRS allocation into measurable QOF improvement against your ICB's cardiovascular and diabetes targets? Is it absorbing GP workload around acute trust discharge reconciliation? Is it running a structured care home review programme across an outer south or south-west London cohort? Is it a defensive move because solo recruitment failed twice in central London's competitive market and the network is haemorrhaging ARRS underspend back to NHS England?

These objectives look identical in a job description but produce very different procurement decisions. The providers that win each one are not the same. Spending one hour with your Practice Managers and prescribing lead before you go to market pays back many times over in how confidently you can compare bids.

Governance — non-negotiable

Ask for documented evidence of each.

  • Cyber Essentials Certified — the certificate, not a claim
  • NHS DSPT compliant — current submission, not a screenshot
  • GPhC-registered pharmacists with documented weekly supervision
  • Clinical indemnity in place for every named role
  • DPIA template specific to your PCN contract — not a generic
  • Named QA lead independent of delivery and named on your account
  • HSCN-secured infrastructure for any remote prescribing component

Supervision is where most providers fail audit

Who actually supervises the pharmacist?

The single biggest difference between a good and a bad ARRS deployment in London is real, weekly, evidenced clinical supervision. NWL, NCL, NEL, SEL and SWL ICBs all look for it; an ARRS audit will eventually catch its absence. Ask: who supervises the pharmacist, how often, and how is it evidenced for audit? If the answer is vague — "the practice supervises", "supervision happens organically", "the pharmacist is senior enough not to need it" — walk away.

  • Weekly clinical supervision from a senior pharmacist independent of line management
  • Documented to ARRS standard for ICB inspection
  • Real-time escalation route — the pharmacist has someone to call mid-clinic
  • Supervision schedule and notes available to the PCN Clinical Director on request

London-specific capability

What a London provider has to be able to do.

  • Multilingual pharmacist capacity — Bengali, Urdu, Hindi, Punjabi, Gujarati, Polish, Arabic, French
  • Discharge reconciliation across all five London ICB footprints — different trust discharge formats, one programme
  • Care home in-reach reviews across outer south and south-west London — the highest care home density in the capital
  • Cardiovascular and diabetes optimisation for South Asian, Black African and Caribbean cohorts
  • Pharmacist time at London prices — without losing supervision, governance or outcome reporting
  • Surge capacity from a hub for flu, COVID and winter pressures — not 'we'll try to find a locum'

Outcomes — how you'll know it's working

What every monthly report should contain.

  • Outcomes mapped to your London ICB's Medicines Optimisation priorities and your PCN IIF
  • SMR completions by cohort (polypharmacy 65+, care home, frailty, BME)
  • Discharge medicines reconciliation completions within the IIF window, by acute trust
  • High-risk drug monitoring gaps closed (DMARDs, lithium, amiodarone, anticoagulants)
  • Prescribing-budget impact from switch programmes
  • QA sign-off on every report before it leaves the provider

London-specific questions to ask in every pitch.

  1. How will you align our programme to the relevant London ICB's published Medicines Optimisation priorities — specifically?
  2. How will you handle discharge medicines reconciliation from our local acute trusts inside the IIF window — naming the trusts?
  3. What multilingual pharmacist capacity do you have for our patient demographic — by named language, not "we can find someone"?
  4. How will you handle care home in-reach for our outer-borough cohort — by named home, not theoretically?
  5. What's your mobilisation timeline for a London PCN starting in the next quarter — in weeks, not months?
  6. Show us a sample monthly outcomes report from a comparable London PCN — anonymised. If they can't, that tells you what their reporting actually looks like.

Red flags

Walk away if you hear any of these.

  • 'We can't share our governance documentation' — they don't have it
  • Pharmacists supervised only by their own line manager
  • 'Cover is best efforts' rather than a written cover SLA
  • No monthly outcomes reporting included as standard
  • Generic locum-style day rates billed against ARRS — won't survive audit
  • Refusal to name the lead pharmacist on your account
  • No multilingual capacity for a borough where 40%+ of the list speaks a language other than English at home

How BCS approaches London.

Bespoke Clinical Services is a national clinical pharmacist provider built specifically for Primary Care Networks, with a clinical hub in Chiswick (W4). In London we deploy ARRS-compliant clinical pharmacists and pharmacy technicians as part of a managed clinical team — with weekly senior pharmacist supervision, same-week sickness and leave cover, full Cyber Essentials and NHS DSPT compliance, GPhC-registered prescribers, multilingual capacity across the languages spoken in London's PCN lists, and a single SLA per PCN.

The 12-month plan is mapped onto the relevant London ICB's Medicines Optimisation priorities at mobilisation, so the same work counts toward both the PCN's IIF and the ICB's published targets. Mobilisation for a London PCN typically runs 4 to 6 weeks from contract sign-off, with HSCN-secured remote prescribing back-up available sooner where capacity is urgent.

If your London PCN is choosing a pharmacist provider this cycle — or considering switching — we'd welcome a 30-minute discovery conversation.

Talk to our Service Development team

30-minute discovery call. We'll show you how BCS maps to your PCN's specific priorities.

Book a discovery call